Rethinking Psychiatric Drugs: A Guide for Informed Consent

Rethinking Psychiatric Drugs: A Guide for Informed Consent

by Grace E. Jackson

Paperback

$22.95
Choose Expedited Shipping at checkout for delivery by Thursday, August 5

Overview

-- Are patients aware of the fact that pharmacological therapies stress the brain in ways which may prevent or postpone symptomatic and functional recovery ?







====================================================



Rethinking Psychiatric Drugs: A Guide for Informed Consent is a critical appraisal of the medications which an estimated 20% of Americans consume on a regular (and sometimes involuntary) basis.



It is the philosophically, epidemiologically, and scientifically supported revelation of how and why psychiatry's drug therapies have contributed to a standard of care which frequently does more to harm than to cure.



Extensively researched and documented, the book addresses:



-- the process by which psychiatric drugs reach the market



-- the history and philosophy of Evidence Based Medicine



-- the common flaws in research methodologies which negate the validity of the psychiatric RCT (Randomized Controlled Trial)



-- the problem of allostatic load (how drugs stress the body)



-- the history, long term effects, and utility of the drugs used to suppress symptoms of depression, psychosis, inattention and hyperactivity



-- the effectiveness of alternatives to medication







Rethinking Psychiatric Drugs: A Guide for Informed Consent exposes the current crisis in medical ethics and epistemology, and attempts to restore to psychiatry an authentically informed consent to care.


Related collections and offers

Product Details

ISBN-13: 9781420867428
Publisher: AuthorHouse
Publication date: 07/27/2005
Pages: 420
Product dimensions: 6.00(w) x 9.00(h) x 0.93(d)

Customer Reviews